Osteopontin expression in a group of lymph node negative breast cancer patients

Applied logistic regression

1990 • 37,000 citations

Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast Cancer

1993 • 777 citations

Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces.

1992 • 459 citations

cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)

1990 • 361 citations

Osteopontin expression and distribution in human carcinomas.

1994 • 331 citations

Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.

1997 • 284 citations

Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.

1996 • 240 citations

Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

1995 • 234 citations

Osteopontin expression in lung cancer

1996 • 191 citations

Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

1988 • 187 citations

Tumor progression in four mammary epithelial cell lines derived from the same patient.

1990 • 174 citations

Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin

1996 • 151 citations

CODING ORDINAL INDEPENDENT VARIABLES IN MULTIPLE REGRESSION ANALYSES

1987 • 139 citations

A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells

1983 • 113 citations

Site‐directed mutagenesis of the arginine‐glycine‐aspartic acid sequence in osteopontin destroys cell adhesion and migration functions

1995 • 105 citations

Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.

1997 • 105 citations

Tumor progression and metastasis in murine D2 hyperplastic alveolar nodule mammary tumor cell lines

1993 • 95 citations

Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci.

1995 • 86 citations

Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin.

1994 • 80 citations

Recombinant GST‐human osteopontin fusion protein is functional in RGD‐dependent cell adhesion

1994 • 79 citations

Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67

1997 • 78 citations

ras mutation and expression of theras-regulated genes osteopontin and cathepsin L in human esophageal cancer

1997 • 77 citations

Quantification of osteopontin in human plasma with an ELISA: Basal levels in pre- and postmenopausal women

1996 • 63 citations

The predictive power of semiquantitative immunohistochemical assessment of p53 and c-erb B-2 in lymph node-negative breast cancer

1996 • 54 citations

Osteopontin: Role in Cell Signalling and Adhesion

1995 • 20 citations